This is a great explanation, I think many try and attach some meaning behind what these pros do but it is really just trying to make money off others. They need movement and they simply pry on other investors. They have no interest in what the company or product is. It is just trading. None of the stock price action has anything to do with leronlimab or the fda. It matters when a company is fund raising and trying to uplist but the product development is moving forward despite this.